Supernus Pharmaceuticals Inc’s filing revealed that its President, CEO Khattar Jack A. unloaded Company’s shares for reported $1.09 million on Aug 28 ’25. In the deal valued at $45.12 per share,24,150 shares were sold. As a result of this transaction, Khattar Jack A. now holds 1,092,633 shares worth roughly $49.3 million.
Then, Khattar Jack A. sold 10,650 shares, generating $479,782 in total proceeds. Upon selling the shares at $45.05, the President, CEO now owns 1,078,004 shares.
Before that, NEWHALL CHARLES W III sold 3,588 shares. Supernus Pharmaceuticals Inc shares valued at $161,496 were divested by the Director at a price of $45.01 per share. As a result of the transaction, NEWHALL CHARLES W III now holds 129,644 shares, worth roughly $5.85 million.
Cantor Fitzgerald upgraded its Supernus Pharmaceuticals Inc [SUPN] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in mid February from “an Overweight” to “a Neutral”. Cantor Fitzgerald began covering SUPN with “an Overweight” recommendation on January 06, 2025. Piper Sandler revised its rating on September 11, 2024. It rated SUPN as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of SUPN
On Friday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock fall -0.55% to $45.12. Over the last five days, the stock has gained 0.53%. Supernus Pharmaceuticals Inc shares have risen nearly 29.28% since the year began. Nevertheless, the stocks have risen 24.78% over the past one year. While a 52-week high of $45.60 was reached on 08/25/25, a 52-week low of $29.16 was recorded on 05/07/25.
Levels Of Support And Resistance For SUPN Stock
The 24-hour chart illustrates a support level at 44.87, which if violated will result in even more drops to 44.63. On the upside, there is a resistance level at 45.47. A further resistance level may holdings at 45.83.
How much short interest is there in Supernus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2025-08-15, dropping by -0.4 million shares to a total of 4.7 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 5.1 million shares. There was a decline of -8.45%, which implies that there is a negative sentiment for the stock.
